中国医院用药评价与分析2024，Vol.24Issue(6)：764-768,5.DOI:10.14009/j.issn.1672-2124.2024.06.028
中药干预人肺腺癌A549细胞的实验研究进展
Progress of Experimental Research on Intervention of Traditional Chinese Medicine in Human Lung Adenocarcinoma A549 Cells
摘要
Abstract
Among malignant tumors,lung cancer has the highest morbidity and mortality both domestically and worldwide.Non-small cell lung cancer is the main type of lung cancer,while lung adenocarcinoma is a common pathologic type of non-small cell lung cancer.A549 cells are a type of experimental lung cancer cells commonly used as research models for lung adenocarcinoma.Due to the characteristics of low toxicity,significant efficacy and high safety of traditional Chinese medicine,more and more studies focus on the mechanism of traditional Chinese medicine in the treatment of lung cancer.At present,experimental studies on the effects of traditional Chinese medicine on lung adenocarcinoma A549 cells have been continuously carried out.After reviewing a large amount of relevant literature,the studies are categorized into intervention studies of traditional Chinese medicine compounds and traditional Chinese medicine monomers,which were reviewed.The following is a summary of these studies.关键词
肺腺癌/A549细胞/中药/实验研究Key words
Lung adenocarcinoma/A549 cells/Traditional Chinese medicine/Experimental research分类
医药卫生引用本文复制引用
周佳静,张利,侯爱画,崔长磊,严吉峰..中药干预人肺腺癌A549细胞的实验研究进展[J].中国医院用药评价与分析,2024,24(6):764-768,5.基金项目
山东省自然科学基金青年项目(No.ZR2021QH023) （No.ZR2021QH023）
山东省医务职工科技创新计划项目(No.SDYWZGKCJHLH202277) （No.SDYWZGKCJHLH202277）
